2024
DOI: 10.1007/s11657-023-01359-y
|View full text |Cite
|
Sign up to set email alerts
|

Healthcare professionals’ perspectives and experiences of osteoporosis medication treatment: a qualitative systematic review

Fatima Rezae,
Ayano Kelly,
Sagarika Dey
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 70 publications
0
1
0
Order By: Relevance
“…Underutilization of osteoporosis screening may be related to a variety of issues including logistical difficulties, concerns about the accuracy of lumbar T-scores in the degenerative spine, or lack of consensus regarding the implications of low bone density for surgical management. In the absence of clear specialty-specific guidelines addressing bone density in elective lumbar fusion, many surgeons may feel uncomfortable assuming the responsibility for osteoporosis screening and treatment [ 17 , 18 ]. Inadequate insurance coverage and reimbursement practices can also discourage providers from ordering diagnostic testing or prescribing pharmacologic therapies, and may make patient adherence to treatment cost-prohibitive [ 19 , 20 ].…”
Section: Introductionmentioning
confidence: 99%
“…Underutilization of osteoporosis screening may be related to a variety of issues including logistical difficulties, concerns about the accuracy of lumbar T-scores in the degenerative spine, or lack of consensus regarding the implications of low bone density for surgical management. In the absence of clear specialty-specific guidelines addressing bone density in elective lumbar fusion, many surgeons may feel uncomfortable assuming the responsibility for osteoporosis screening and treatment [ 17 , 18 ]. Inadequate insurance coverage and reimbursement practices can also discourage providers from ordering diagnostic testing or prescribing pharmacologic therapies, and may make patient adherence to treatment cost-prohibitive [ 19 , 20 ].…”
Section: Introductionmentioning
confidence: 99%